Traws Pharma, Inc. · NASDAQ:TRAW
Traws Pharma, Inc. shareholders
As of Jun 30, 2026, 32 institutions reported holding Traws Pharma, Inc., 40.1% of its shares. Largest: Orbimed Advisors LLC, Ally Bridge Group (NY) LLC and Adage Capital Partners Gp, L.L.C. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Traws Pharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLC | 1.2M | 7.8% | +598K | Aug 14, 2026 |
| Ally Bridge Group (NY) LLC | 786K | 5.1% | new | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | 730K | 4.8% | no change | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | 598K | 3.9% | +444K | Aug 14, 2026 |
| Lynx1 Capital Management LP | 559K | 3.6% | +544K | Aug 13, 2026 |
| Ikarian Capital, LLC | 478K | 3.1% | −200K | Aug 14, 2026 |
| Sphera Funds Management LTD. | 398K | 2.6% | new | Aug 14, 2026 |
| Vanguard | 385K | 2.5% | +298K | Aug 13, 2026 |
| Jane Street | 216K | 1.4% | +195K | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | 164K | 1.1% | new | Aug 14, 2026 |